Mg. Juarezreyes et al., CLOZAPINE ELIGIBILITY - THE EFFECT OF STRINGENT CRITERIA ON ETHNIC, GENDER AND AGE SUBGROUPS OF SCHIZOPHRENIC-PATIENTS, Progress in neuro-psychopharmacology & biological psychiatry, 20(8), 1996, pp. 1341-1352
1. The purpose of this retrospective chart review study was to determi
ne whether broad and stringent criteria differentially impact clozapin
e eligibility in ethnic, gender, and age subgroups of schizophrenic pa
tients. 2. 505 patient charts were selected from a random cluster samp
le of mental health patients known to the city and county of San Franc
isco. Information related to clozapine eligibility was abstracted by t
rained non-clinical personnel. The impact of subgroup membership on el
igibility was examined using logistic regression procedures. 3. Even u
nder the broadest interpretation of FDA requirements for clozapine use
, Asian patients were less likely to be eligible, since fewer Asian pa
tients met clozapine treatment requirements. Under more stringent elig
ibility criteria, older patients were more likely to be excluded from
eligibility when TD does not automatically satisfy treatment criteria,
and younger patients were more likely to lose eligibility if the numb
er of required adequate medication trials increases to three. 4. Broad
eligibility criteria tend to differentially exclude Asian patients wh
ile more stringent criteria differentially exclude younger and older p
atients.